10-Q: Quantum Cyber NV Pivots to AI/Drones, Reports Q3 Losses
Quarterly Report
Quantum Cyber NV (formerly Mainz Biomed) reported its Q3 2026 results, highlighting a strategic pivot towards AI, drones, and quantum technologies, alongside continued operational losses and a significant cash burn.
Summary
- Quantum Cyber N.V. (formerly Mainz Biomed N.V.) has reported its financial results for the quarter ended September 30, 2026.
- The company has undergone a significant strategic pivot, moving away from its former colorectal cancer screening business to focus on autonomous defense platforms, drones, and quantum technologies.
- Revenue from continuing operations for the three months ended September 30, 2026, was $966,833, primarily from the recently acquired metal stamping business (Arcade Technology).
- The company reported a net loss of $5,381,441 for the three months ended September 30, 2026, and a net loss of $21,479,903 for the nine months ended September 30, 2026.
- Significant operating expenses include sales and marketing, research and development (including in-process R&D for quantum antenna technology), and general and administrative costs.
- The company has secured a funding commitment of up to $8 million from CEO David Lazar through November 30, 2027, and has an at-the-market offering of up to $100 million.
- A material weakness in internal control over financial reporting has been identified, with remediation efforts underway.
- The company is continuing to build out its Bridgeport, Connecticut facility for drone manufacturing, with expected commencement of manufacturing and sales in early 2027.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a cautious outlook due to significant ongoing losses, reliance on future financing, and the early stage of its new technology ventures, despite recent strategic acquisitions.
Positives
- Generated $966,833 in revenue from continuing operations in Q3 2026, primarily from the acquired metal stamping business.
- Secured a $8 million funding commitment from CEO David Lazar through November 30, 2027, to address potential liquidity gaps.
- Successfully regained compliance with Nasdaq minimum bid price requirements.
- Acquired Arcade Technology LLC, providing a manufacturing foundation for its Quantum Drones platform and generating immediate revenue.
- Entered into strategic license agreements for drone technology (BP United) and quantum antenna technology (Project LightShift).
- The company believes its cash on hand and the funding commitment alleviate substantial doubt about its ability to continue as a going concern for at least the next twelve months.
Negatives
- Reported a net loss of $5,381,441 for Q3 2026 and $21,479,903 for the nine months ended September 30, 2026.
- Significant increase in operating expenses, particularly in R&D and G&A, related to the new strategic focus.
- Identified a material weakness in internal control over financial reporting.
- The company has not yet commenced the manufacture or sale of drones and has not received any purchase orders for drones.
- Reliance on future financing, including an at-the-market offering and the CEO's commitment, which may not be fully realized or may be dilutive.
- The company has a limited operating history in its current business lines (AI, drones, quantum technologies).
Risks
- The company's ability to continue as a going concern depends on obtaining additional financing, including the CEO's commitment and potential equity offerings.
- Further delays in completing the build-out of the Bridgeport facility and commencing drone manufacturing.
- Uncertainty regarding market acceptance of drone products, as no purchase orders have been received.
- Dependence on license agreements, including the delivery of a quantum antenna prototype by Project LightShift.
- The material weakness in internal control over financial reporting could lead to misstatements or delays in filings.
- The evolving regulatory framework for AI and unmanned aircraft systems (UAS) could impact operations and compliance costs.
- Competition from companies with greater financial and technical resources.
- Potential dilution to shareholders from future equity financings and the conversion of preferred shares.
Future Outlook
The company anticipates investing in research and development to commercialize its drone technology, aiming to integrate AI and quantum computing for next-generation autonomous systems. Expected commencement of drone manufacturing and sales is early 2027. The company's ability to continue as a going concern is supported by its current cash position and a $8 million funding commitment from its CEO, but future financing remains critical.
Management Comments
- The Company's intention is to build out the manufacturing capabilities at the Bridgeport facility for its Quantum Drones platform.
- We anticipate investing in research and development to power the ultimate commercialization of our drone technology.
- We currently expect to begin manufacturing and selling drones in early 2027; however, there can be no assurance that we will achieve this timeline or that our drone products will achieve market acceptance.
- Based on the Companys cash on hand and the Funding Commitment, management has concluded that its plans alleviate the substantial doubt about the Companys ability to continue as a going concern, and that the Company will have sufficient resources to meet its obligations as they become due for at least one year after the date these condensed consolidated financial statements are issued.
Industry Context
StockSavvy.ai notes that Quantum Cyber N.V.'s pivot aligns with a broader industry trend towards integrating AI and quantum computing for advanced autonomous systems, particularly in defense and logistics. However, the company faces intense competition from established tech giants and emerging players in these nascent fields.
Comparison to Industry Standards
- The company's net loss of $21.5 million for the nine months ended September 30, 2026, is substantial for a company generating only $0.97 million in revenue from its metal stamping business, indicating a high burn rate typical of early-stage technology development.
- The significant increase in R&D expenses ($1.58 million for nine months) reflects investment in new technologies, which is common in the AI and quantum computing sectors, but requires substantial future revenue to justify.
- The company's reliance on external financing, including a $100 million ATM offering and an $8 million CEO commitment, is a common strategy for companies in capital-intensive technology sectors, but carries inherent risks of dilution and funding uncertainty.
- The identified material weakness in internal controls is a concern, especially for a company seeking to grow and attract institutional investment, though remediation efforts are underway.
Legal Proceedings
- Settlement agreement reached with Boustead Securities, LLC for $250,000 to resolve a legal action and arbitration claims.
Related Party Transactions
- David Lazar, CEO and Chair of the Board, purchased preferred shares and converted them into ordinary shares.
- David Lazar provided an $8 million funding commitment through November 30, 2027.
- The company issued ordinary shares to management and the Board for compensation.
- Sale of ColoAlert assets to UTR, an entity partially owned by a former director, which reduced debt owed to UTR.
Stakeholder Impact
- Shareholders may experience dilution from future equity issuances and conversions of preferred shares.
- The company's ability to continue as a going concern relies on future financing, impacting investor confidence.
- Employees may be affected by the ongoing strategic pivot and integration of acquired businesses.
- Customers of the metal stamping business will continue to receive services, while drone customers are awaiting product launch.
Next Steps
- Continue building out the Bridgeport facility for drone manufacturing.
- Begin manufacturing and selling drones, expected in early 2027.
- Pursue additional financing through the at-the-market offering and the CEO's funding commitment.
- Remediate the material weakness in internal control over financial reporting.
- Continue development and commercialization of AI and quantum technologies.
- Seek market acceptance for drone products.
Key Dates
| Date | Description |
|---|---|
| 2026-01-01 | Company ceased to qualify as a foreign private issuer. |
| 2026-02-01 | Decision to exit colorectal cancer screening business. |
| 2026-04-22 | Shareholders approved name change to Quantum Cyber N.V. and ticker symbol change to QUCY. |
| 2026-07-15 | Closing of the Arcade Acquisition (Asset Purchase Agreement and Purchase and Sale Agreement). |
| 2026-09-30 | End of the reporting period for the Q3 2026 Form 10-Q. |
| 2026-10-09 | Entered into Titan Sales Agreement for at-the-market offering. |
| 2026-10-15 | Settlement agreement with Boustead Securities, LLC. |
| 2026-11-11 | David Lazar provided Funding Commitment letter. |
Recommendation
holdThe company is undergoing a significant strategic transformation into high-growth, capital-intensive sectors (AI, quantum, drones). While the acquisition of Arcade Technology provides immediate revenue and a manufacturing base, and the CEO's funding commitment offers some liquidity assurance, the company continues to incur substantial losses, faces significant execution risks in its new ventures, and has identified material weaknesses in internal controls. The lack of drone orders and delayed manufacturing commencement, coupled with reliance on future financing, warrants a cautious 'hold' stance until clearer operational progress and financial stability are demonstrated.
Keywords
Quantum Cyber, Quantum Drones, AI, Autonomous Systems, Drone Technology, Metal Stamping, Quantum Antenna, Form 10-Q
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.